RGIN — Regenicin Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.02m
- -$11.20m
Annual cashflow statement for Regenicin, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
C2018 September 30th | R2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.559 | -0.758 | -0.56 | -0.671 | -0.639 |
| Non-Cash Items | -0.249 | 0.035 | -0.151 | 0 | 0.002 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.712 | 0.457 | 0.588 | 0.646 | 0.61 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.096 | -0.267 | -0.123 | -0.024 | -0.027 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.079 | 0.116 | 0.124 | 0.025 | 0.04 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.017 | -0.151 | 0.001 | 0 | 0.013 |